Biorem, Inc.

  • Market Cap: Micro Cap
  • Industry: Industrial Manufacturing
  • ISIN: CA09068G1046
CAD
2.47
-0.02 (-0.8%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

High Management Efficiency with a high ROCE of 78.89%

 
2

Company has a low Debt to Equity ratio (avg) at times

 
3

Poor long term growth as Net Sales has grown by an annual rate of 10.78% over the last 5 years

 
4

The company has declared Positive results for the last 4 consecutive quarters

 
5

With ROE of 17.30%, it has a fair valuation with a 3.29 Price to Book Value

6

Underperformed the market in the last 1 year

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Industrial Manufacturing

stock-summary
Market cap

CAD 40 Million (Micro Cap)

stock-summary
P/E

19.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.51

stock-summary
Return on Equity

17.30%

stock-summary
Price to Book

3.29

Revenue and Profits:
Net Sales:
11 Million
(Quarterly Results - Sep 2025)
Net Profit:
1 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-8.18%
0%
-8.18%
6 Months
21.67%
0%
21.67%
1 Year
2.92%
0%
2.92%
2 Years
70.34%
0%
70.34%
3 Years
135.24%
0%
135.24%
4 Years
201.22%
0%
201.22%
5 Years
341.07%
0%
341.07%

Biorem, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
10.78%
EBIT Growth (5y)
36.62%
EBIT to Interest (avg)
2.92
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.67
Sales to Capital Employed (avg)
2.83
Tax Ratio
26.64%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
78.89%
ROE (avg)
37.65%

Valuation key factors

Factor
Value
P/E Ratio
19
Industry P/E
Price to Book Value
3.29
EV to EBIT
11.21
EV to EBITDA
9.58
EV to Capital Employed
5.71
EV to Sales
0.98
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
50.91%
ROE (Latest)
17.30%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bearish
Dow Theory
No Trend
No Trend
OBV
Mildly Bearish
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is -24.16% vs 170.91% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is -45.45% vs 340.00% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "11.30",
          "val2": "14.90",
          "chgp": "-24.16%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1.70",
          "val2": "3.20",
          "chgp": "-46.88%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1.20",
          "val2": "2.20",
          "chgp": "-45.45%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "141.80%",
          "val2": "203.30%",
          "chgp": "-6.15%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 48.41% vs -12.80% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 36.36% vs 37.50% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "37.40",
          "val2": "25.20",
          "chgp": "48.41%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "4.90",
          "val2": "3.50",
          "chgp": "40.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.20",
          "val2": "0.30",
          "chgp": "-33.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "3.00",
          "val2": "2.20",
          "chgp": "36.36%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "117.40%",
          "val2": "122.60%",
          "chgp": "-0.52%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Sep'25 - YoYstock-summary

Sep'25
Sep'24
Change(%)
Net Sales
11.30
14.90
-24.16%
Operating Profit (PBDIT) excl Other Income
1.70
3.20
-46.88%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
1.20
2.20
-45.45%
Operating Profit Margin (Excl OI)
141.80%
203.30%
-6.15%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended Sep 2025 is -24.16% vs 170.91% in Sep 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Sep 2025 is -45.45% vs 340.00% in Sep 2024

Annual Results Snapshot (Consolidated) - Dec'24stock-summary

Dec'24
Dec'23
Change(%)
Net Sales
37.40
25.20
48.41%
Operating Profit (PBDIT) excl Other Income
4.90
3.50
40.00%
Interest
0.20
0.30
-33.33%
Exceptional Items
0.00
0.00
Consolidate Net Profit
3.00
2.20
36.36%
Operating Profit Margin (Excl OI)
117.40%
122.60%
-0.52%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 48.41% vs -12.80% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 36.36% vs 37.50% in Dec 2023

stock-summaryCompany CV
About Biorem, Inc. stock-summary
stock-summary
Biorem, Inc.
Industrial Manufacturing
Biorem Inc. is a Canada-based clean technology company. The Company designs, manufactures and distributes a line of air emissions control systems used to eliminate odors, volatile organic compounds (VOCs) and hazardous air pollutants (HAPs). The Company operates through the manufacture and sale of air pollution control systems segment. The Company also offers Biogas Conditioning technologies specializing in biological treatment of hydrogen sulfide. The Company's product solutions include biofilters, biotrickling filters, multi-stage systems, biogas solutions, organics and anaerobic digestion, SK series and engineered media. The Company's service solutions include biological processes and testing, media sampling and analysis, full system review and inspections, and media replacements and spare parts. The Company has over 1,000 installed systems around the world.
Company Coordinates stock-summary
Company Details
7496 Wellington Road 34, Rr 3 , GUELPH ON : N1H 6H9
stock-summary
Tel: 1 519 76791001 519 7679100
stock-summary
Registrar Details